EGFR alone cannot drive the progression of metastatic PCa tumours, but its linked to its upstream fibrinolytic receptor ANXA2, are together known to the PCa and breast cancer progression19,34. The gene discussed is ANXA2; the disease is posterior cortical atrophy.